Infiniplex
Fast-lane Cancer Monitoring and Screening
Startup Seed Health Tech & Life Sciences Est. 2021
Total Raised
$1.1M
Seed
Last Round
$1.1M
1 rounds
Investors
1
1 public
Team
7
11-50 employees
Confidence
89/100
News
1
articles
Patents
1
About
Infiniplex's mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at an accessible and affordable cost. The company's goal is to identify common and rare cancer types through a standard, inexpensive blood test that could be carried out as part of routine checkups, leveraging existing laboratory equipment and know-how. Infiniplex aims to include tumor genomic testing as part of people's standard blood test checkups.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Core Technology
Artificial IntelligenceGenerative AIMachine LearningBiologicalsMoleculesGenes
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
screeningbiomarkerscancer-diagnosticsmachine-learningmonitoringhealthcarebiotechnologyoncologydiagnosticscancermedical-technologiesgeneticsbioinformatics
Funding & Events
May 2022
Seed $1.1M
Terra Venture Partners
News (1)
May 31, 2022 ยท chiportal.co.il
growth-positive
ืงืจืŸ ื˜ืจื” ื•ื ืฆ'ืจ ืคืจื˜ื ืจืก ื‘ื™ืฆืขื” 3 ื”ืฉืงืขื•ืช ื‘ื—ื‘ืจื•ืช ืกื˜ืืจื˜-ืืค ื—ื“ืฉื•ืช ื‘ื”ื™ืงืฃ ื›ื•ืœืœ ืฉืœ ื› 3 ืžื™ืœื™ื•ืŸ ื“ื•ืœืจ - Chiportal
Investment
Details
Product Stage
R&D
Employees
11-50
Exact Count
12
District
North District
Founded
2021
Registrar
516447414
Locations
Yokne'am Illit, Israel
Links
Website
LinkedIn
Admin
Last Update
Mar 18, 2025
Verified by
Yotam Maman
Claimed
Yes
Missing
video or image, markets, not claimed
Team (7)
Zeev Russak
CEO
Founder
Ofer Peleg
CSO
Founder
Yael Furman
VP Clinical and Regulatory affairs
Adi Telem
Research Assistant
Itamar Caspi
Bioinformatician
Shira Sagee
Progect manager
Ortal Cohen
R&D Manager
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2022-05-15T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)